{
  "report_rows": [
    {
      "kpi": "EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1.12 vs. cons $1.08",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net interest income (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.65B vs. cons ~$3.62B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Noninterest (fee) income (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1.63B vs. cons ~$1.58B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 NII growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~+2-3% vs. cons ~+2.5% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 noninterest income growth",
      "prediction": "BETTER",
      "answer": "guide ~+10% (HSD-to-low-double) vs. cons ~+8% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2/2H NIM",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.02% stable, 2H expansion vs. cons ~3.02% (Q2 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 buyback program",
      "prediction": "UNCHANGED",
      "answer": "guide ~$5.0B (~$1.2B Q2) vs. cons ~$5.0B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 expense growth / operating leverage",
      "prediction": "UNCHANGED",
      "answer": "guide ~+1.75% opex vs. cons ~+1.75% (FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "ROTCE framework / CEO continuity",
      "prediction": "UNCHANGED",
      "answer": "guide 14% '26 / 15% '27 / 16-18% LT vs. cons ~14% (FY2026-27)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -0.5,
  "day5_path": "FADE",
  "day5_rationale": "A modest EPS beat is likely, but its quality is low \u2014 driven by capital-markets/trading and buyback-reduced share count rather than NII, where FY guide stays capped at +2-3% (no rate cuts, deposit-cost creep). With the stock already up ~9% since the CEO news and sitting near 52-week highs ($53.27) priced for good news, a clean-but-not-blowout print plus a continuity-only handoff narrative leaves little upside fuel. Out-period math (trading normalization, flat-to-down sequential fees guide, NIM ramp deferred to 2H/2027) caps positive revisions, so an initial pop tends to give back as estimates hold flat rather than move up.",
  "day5_confidence": "LOW"
}